BicycleTx Ltd  

Cambridge, 
United Kingdom
https://www.bicycletherapeutics.com
  • Booth: 33165

 Products

  • Zelenectide pevedotin
    Zelenectide pevedotin is composed of a highly selective Nectin-4–targeted bicyclic peptide, connected to an MMAE cytotoxic payload via a cleavable linker. Upon binding to Nectin-4, MMAE is released by proteases in the tumor microenvironment, triggering tumor cell death and tumor regression. Zelenectide pevedotin is designed to have rapid distribution to tumor cells for efficient delivery of MMAE into the tumor, and a short plasma half-life to limit prolonged overall systemic exposure and potential for AEs. The molecule is currently being evaluated in several clinical trials. The Phase I/II Duravelo-1 trial is studying zelenectide pevedotin in several Nectin-4 associated tumors, while the Phase II/III Duravelo-2 trial is studying zelenectide pevedotin as a treatment for metastatic urothelial cancer. Studies using NECTIN4 gene amplification as a biomarker for zelenectide pevedotin therapy stratification in breast, lung and other cancers are underway.
     ...

  • BT5528
    BT5528 targets the erythropoietin-producing hepatocellular A2 receptor (EphA2) with a clinical safety profile that is differentiated from previous drugs developed against this target, validating the potential for BDCs against both proven and challenging novel drug targets. The molecule is composed of EphA2 targeting Bicycle®, a valine-citrulline (val-cit) cleavable linker and a MMAE cytotoxin payload. BT5528 is currently being evaluated in a Phase I/II clinical trial as a monotherapy and in combination with IO agent. EphA2 IHC status for patients enrolled in the study are being recorded for future assessment as a potential predictor of efficacy.
     ...

Categories

Cancer Types
  • Breast Cancer
  • Genitourinary Cancer
  • Lung Cancer
  • Metastatic Disease
    • Categories:
  • Biomarkers
  • Clinical Trials
  • Developmental Therapeutics
    • Loading ...

    :
    :


    Legend
    Available Timeslot
    Scheduled Appointment
    Personal Appointments
    Request
    Blocked Timeslot
    Restricted Timeslot
    Cancelled
    Declined